These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8555063

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors.
    Ríos A, Cañizo MC, Sanz MA, Vallespí T, Sanz G, Torrabadella M, Gomis F, Ruiz C, San Miguel JF.
    Br J Haematol; 1990 May; 75(1):26-33. PubMed ID: 2375920
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Pathohistological characteristics of myelodysplastic syndromes: diagnostic and prognostic significance].
    Marisavljević D, Cemerikić V, Rolović Z, Bosković D, Colović M.
    Srp Arh Celok Lek; 2005 May; 133(3-4):162-9. PubMed ID: 16206706
    [Abstract] [Full Text] [Related]

  • 30. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.
    Huang TC, Ko BS, Tang JL, Hsu C, Chen CY, Tsay W, Huang SY, Yao M, Chen YC, Shen MC, Wang CH, Tien HF.
    Leukemia; 2008 Mar; 22(3):544-50. PubMed ID: 18094713
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).
    Yao CY, Hou HA, Lin TY, Lin CC, Chou WC, Tseng MH, Chiang YC, Liu MC, Liu CW, Kuo YY, Wu SJ, Liao XW, Lin CT, Ko BS, Chen CY, Hsu SC, Li CC, Huang SY, Yao M, Tang JL, Tsay W, Liu CY, Tien HF.
    Oncotarget; 2016 Sep 27; 7(39):63177-63188. PubMed ID: 27527853
    [Abstract] [Full Text] [Related]

  • 34. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
    Chen BA, Gao C, Ding J, Ding JH, Sun YY, Zhao G, Cheng J, Wang J, Bao W, Song HH, Xia GH, Ma JL, Wu LL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec 27; 17(6):1472-6. PubMed ID: 20030929
    [Abstract] [Full Text] [Related]

  • 35. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J, Shao Z, Liu H, Li K, Song L, Zhang Y, Zheng Y, Chen G, Chu Y, He H, Zhao M, He G, Feng B, Hao Y, Yang T, Yang C.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul 27; 22(7):351-4. PubMed ID: 11877096
    [Abstract] [Full Text] [Related]

  • 36. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S, Kanamaru A, Takemoto Y, Kakishita E, Nagai K.
    Br J Haematol; 1993 Jun 27; 84(2):219-26. PubMed ID: 8398821
    [Abstract] [Full Text] [Related]

  • 37. High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS).
    Mohamedali AM, Gäken J, Ahmed M, Malik F, Smith AE, Best S, Mian S, Gaymes T, Ireland R, Kulasekararaj AG, Mufti GJ.
    Leukemia; 2015 Sep 27; 29(9):1928-38. PubMed ID: 25943179
    [Abstract] [Full Text] [Related]

  • 38. Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes.
    Lambertenghi-Deliliers G, Annaloro C, Oriani A, Soligo D, Pozzoli E, Polli EE.
    Ann Hematol; 1993 Feb 27; 66(2):85-91. PubMed ID: 8448244
    [Abstract] [Full Text] [Related]

  • 39. Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.
    Kelaidi C, Braun T, Arana R, Marceau-Renaut A, Lazarian G, Soret J, Cereja S, Letestu R, Eclache V, Lusina D, Baran-Marszak F, Ades L, Preudhomme C, Martin A, Fenaux P, Gardin C.
    Leuk Res; 2018 Aug 27; 71():67-74. PubMed ID: 30025278
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.